United States · Platforms & data · MarketBeat
HLS Therapeutics Targets 2027 Growth With Cardiovascular Expansion and New Deals
HLS Therapeutics (TSE:HLS) outlined plans to build on its cardiovascular portfolio and pursue additional business-development opportunities as the specialty pharmaceutical company…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)


